Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 6
1953 2
1955 1
1961 1
1964 6
1965 4
1966 2
1967 4
1968 6
1969 11
1970 7
1971 11
1972 14
1973 10
1974 19
1975 9
1976 14
1977 24
1978 18
1979 29
1980 28
1981 46
1982 37
1983 40
1984 57
1985 57
1986 48
1987 58
1988 65
1989 78
1990 59
1991 54
1992 72
1993 71
1994 82
1995 52
1996 71
1997 69
1998 72
1999 69
2000 107
2001 77
2002 78
2003 99
2004 99
2005 112
2006 102
2007 108
2008 104
2009 111
2010 95
2011 105
2012 134
2013 121
2014 134
2015 138
2016 133
2017 129
2018 121
2019 129
2020 138
2021 168
2022 140
2023 125
2024 128
2025 130
2026 65

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,170 results

Results by year

Filters applied: . Clear all
Page 1
Optimal Antithrombotics for Ischemic Stroke and Concurrent Atrial Fibrillation and Atherosclerosis: A Randomized Clinical Trial.
Okazaki S, Tanaka K, Yazawa Y, Doijiri R, Koga M, Ihara M, Yamamoto S, Kamiyama K, Honda Y, Uchida K, Yoshimoto T, Asakura K, Omae K, Tanaka K, Maeda H, Yamamoto H, Hirano T, Toyoda K, Iguchi Y, Noguchi T, Okada Y, Kitagawa K, Sakai N, Yamagami H; ATIS-NVAF Trial Investigators. Okazaki S, et al. Among authors: maeda h. JAMA Neurol. 2025 Dec 1;82(12):1227-1234. doi: 10.1001/jamaneurol.2025.3662. JAMA Neurol. 2025. PMID: 41051787 Clinical Trial.
Evolutionary histories of breast cancer and related clones.
Nishimura T, Kakiuchi N, Yoshida K, Sakurai T, Kataoka TR, Kondoh E, Chigusa Y, Kawai M, Sawada M, Inoue T, Takeuchi Y, Maeda H, Baba S, Shiozawa Y, Saiki R, Nakagawa MM, Nannya Y, Ochi Y, Hirano T, Nakagawa T, Inagaki-Kawata Y, Aoki K, Hirata M, Nanki K, Matano M, Saito M, Suzuki E, Takada M, Kawashima M, Kawaguchi K, Chiba K, Shiraishi Y, Takita J, Miyano S, Mandai M, Sato T, Takeuchi K, Haga H, Toi M, Ogawa S. Nishimura T, et al. Among authors: maeda h. Nature. 2023 Aug;620(7974):607-614. doi: 10.1038/s41586-023-06333-9. Epub 2023 Jul 26. Nature. 2023. PMID: 37495687 Free PMC article.
Lymph node macrophage-targeted interferon alpha boosts anticancer immune responses by regulating CD169-positive phenotype of macrophages.
Fukuda R, Fujiwara Y, Maeda H, Pan C, Minayoshi Y, Yano H, Mizuta Y, Takano M, Yamada R, Saito Y, Hirata K, Imoto S, Yamasaki K, Oniki K, Saruwatari J, Otagiri M, Watanabe H, Komohara Y, Maruyama T. Fukuda R, et al. Among authors: maeda h. Mol Cancer. 2025 May 3;24(1):132. doi: 10.1186/s12943-025-02324-8. Mol Cancer. 2025. PMID: 40319320 Free PMC article.
Serotype distribution among adults with community-acquired pneumococcal pneumonia in Japan between 2019 and 2022: A multicenter observational study.
Maeda H, Ito I, Sando E, Hamao N, Shirata M, Dhoubhadel BG, Ntiamoah DO, Oi I, Nishioka K, Fujii H, Okamura K, Inoue T, Yamada T, Niibayashi S, Tsukino M, Fujii Y, Tsuchiya M, Nakahara Y, Hasegawa Y, Nakagawa A, Sugita T, Ito A, Sakai N, Kaji Y, Toyoda Y, Urata T, Asoh N, Nishiyama A, Yagiuchi A, Morikawa T, Ushiki A, Ishida M, Morimoto K. Maeda H, et al. Hum Vaccin Immunother. 2025 Dec;21(1):2518847. doi: 10.1080/21645515.2025.2518847. Epub 2025 Jun 27. Hum Vaccin Immunother. 2025. PMID: 40576179 Free PMC article.
Clonal expansion in normal tissues.
Maeda H, Kakiuchi N. Maeda H, et al. Cancer Sci. 2024 Jul;115(7):2117-2124. doi: 10.1111/cas.16183. Epub 2024 Apr 16. Cancer Sci. 2024. PMID: 38623936 Free PMC article. Review.
Carbon monoxide-loaded red blood cells ameliorate metabolic dysfunction-associated steatohepatitis progression via enhancing AMP-activated protein kinase activity and inhibiting Kupffer cell activation.
Yanagisawa H, Maeda H, Noguchi I, Tanaka M, Wada N, Nagasaki T, Kobayashi K, Kanazawa G, Taguchi K, Chuang VTG, Sakai H, Nakashima H, Kinoshita M, Kitagishi H, Iwakiri Y, Sasaki Y, Tanaka Y, Otagiri M, Watanabe H, Maruyama T. Yanagisawa H, et al. Among authors: maeda h. Redox Biol. 2024 Oct;76:103314. doi: 10.1016/j.redox.2024.103314. Epub 2024 Aug 17. Redox Biol. 2024. PMID: 39163766 Free PMC article.
Effect of Cumulative Exposure on the Efficacy of Paroxetine: A Population Pharmacokinetic-Pharmacodynamic and Machine Learning Analyses.
Shigetome K, Egashira T, Tomita T, Higa N, Iwashita K, Morita K, Nishimura M, Kaneko T, Maeda H, Yamada KD, Kajiwara-Morita A, Oniki K, Yasui-Furukori N, Saruwatari J. Shigetome K, et al. Among authors: maeda h. CPT Pharmacometrics Syst Pharmacol. 2025 Jun;14(6):1119-1127. doi: 10.1002/psp4.70032. Epub 2025 May 13. CPT Pharmacometrics Syst Pharmacol. 2025. PMID: 40358139 Free PMC article.
Electronic Patient-Reported Outcomes With Vital Sign Monitoring During Trastuzumab Deruxtecan Therapy: The PRO-DUCE Randomized Clinical Trial.
Kikawa Y, Uemura Y, Taira T, Kitagawa C, Maeda H, Kato H, Hashimoto N, Hosoda M, Hamanaka Y, Tanabe Y, Yoshida T, Tane K, Takabatake D, Ishikawa T, Iwamoto T, Yamaguchi T, Takiguchi D, Mukai H, Taira N, Sangai T. Kikawa Y, et al. Among authors: maeda h. JAMA Netw Open. 2025 Aug 1;8(8):e2527403. doi: 10.1001/jamanetworkopen.2025.27403. JAMA Netw Open. 2025. PMID: 40815510 Free PMC article. Clinical Trial.
4,170 results